Tyme
Dr. Paul Oberstein is Director of Gastrointestinal Medical Oncology and Assistant Director of the Pancreatic Cancer Center in the Perlmutter Cancer Center at NYU Langone Health.
His practice is focused on the management and treatment of gastrointestinal malignancies with a primary focus on pancreatic cancer. His research focus is on developing novel therapeutics and he leads clinical trial efforts in the GI group at the Perlmutter Cancer Center. Dr. Oberstein has designed and initiated innovative translational and clinical trials including studies evaluating the impact of epithelial-stromal interactions in pancreatic cancer. This work, as well as ongoing studies of tumor cachexia, have been funded by the American Society of Clinical Oncology, the Pancreatic Cancer Action Network, and the NCI.
This person is not in the org chart
This person is not in any offices
Tyme
Tyme Technologies, Inc. is a research and development company focused on creating medicines that utilizes the body’s immune system to treat diseases. We at Tyme believe that the body has the ability to fight off major diseases and heal itself.